Authors:
Vogen, SM
Paczkowski, NJ
Kirnarsky, L
Short, A
Whitmore, JB
Sherman, SA
Taylor, SM
Sanderson, SD
Citation: Sm. Vogen et al., Differential activities of decapeptide agonists of human C5a: the conformational effects of backbone N-methylation, INT IMMUNO, 1(12), 2001, pp. 2151-2162
Authors:
Davis, DP
Gallo, G
Vogen, SM
Dul, JL
Sciarretta, KL
Kumar, A
Raffen, R
Stevens, FJ
Argon, Y
Citation: Dp. Davis et al., Both the environment and somatic mutations govern the aggregation pathway of pathogenic immunoglobulin light chain, J MOL BIOL, 313(5), 2001, pp. 1021-1034
Authors:
Kirnarsky, L
Prakash, O
Vogen, SM
Nomoto, M
Hollingsworth, MA
Sherman, S
Citation: L. Kirnarsky et al., Structural effects of O-glycosylation on a 15-residue peptide from the mucin (MUC1) core protein, BIOCHEM, 39(39), 2000, pp. 12076-12082
Authors:
Vogen, SM
Prakash, O
Kirnarsky, L
Sanderson, SD
Sherman, SA
Citation: Sm. Vogen et al., Determination of structural elements related to the biological activities of a potent decapeptide agonist of human C5a anaphylatoxin, J PEPT RES, 54(1), 1999, pp. 74-84
Authors:
Vogen, SM
Finch, AM
Wadi, SK
Thatcher, J
Monk, PN
Taylor, SM
Sanderson, SD
Citation: Sm. Vogen et al., The influence of Lys68 in decapeptide agonists of C5a on C5a receptor binding, activation and selectivity, J PEPT RES, 53(1), 1999, pp. 8-17
Authors:
Short, AJ
Paczkowski, NJ
Vogen, SM
Sanderson, SD
Taylor, SM
Citation: Aj. Short et al., Response-selective C5a agonists: differential effects on neutropenia and hypotension in the rat, BR J PHARM, 128(3), 1999, pp. 511-514